State Of Alaska, Department Of Revenue Eton Pharmaceuticals, Inc. Call Options Transaction History
State Of Alaska, Department Of Revenue
- $9.79 Billion
- Q3 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ETON
# of Institutions
90Shares Held
14.9MCall Options Held
242KPut Options Held
11.8K-
Opaleye Management Inc. Boston, MA2.86MShares$51.5 Million9.75% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA2.03MShares$36.5 Million2.49% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.31MShares$23.6 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT1.18MShares$21.2 Million0.73% of portfolio
-
Geode Capital Management, LLC Boston, MA593KShares$10.7 Million0.0% of portfolio
About Eton Pharmaceuticals, Inc.
- Ticker ETON
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,297,000
- Market Cap $455M
- Description
- Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for th...